David L. Johnson
Net Worth

Last updated: 1 Sep 2022

What is David L. Johnson net worth?

The estimated net worth of Mr. David L. Johnson is at least $4,216,500 as of 1 Sep 2022. He has received compensation worth at least $4,216,500 in Global Blood Therapeutics, Inc..

What is the salary of David L. Johnson?

Mr. David L. Johnson salary is $702,750 per year as Chief Commercial Officer in Global Blood Therapeutics, Inc..

How old is David L. Johnson?

Mr. David L. Johnson is 56 years old, born in 1969.

David L. Johnson insider trading

Global Blood Therapeutics, Inc.

Transaction	Date	Security	Shares	Price per share	Total value
Option	1 Sep 2022	Common Stock	2,763	N/A	N/A
Option	1 Sep 2022	Common Stock	2,208	N/A	N/A
Option	1 Sep 2022	Restricted Stock Units	2,208	N/A	N/A
Option	1 Sep 2022	Restricted Stock Units	2,763	N/A	N/A
Option	1 Aug 2022	Restricted Stock Units	3,125	N/A	N/A
Option	1 Aug 2022	Common Stock	6,770	N/A	N/A
Option	1 Aug 2022	Restricted Stock Units	3,645	N/A	N/A
Option	1 Apr 2022	Restricted Stock Units	4,375	N/A	N/A
Option	1 Apr 2022	Common Stock	4,375	N/A	N/A
Option	1 Mar 2022	Common Stock	2,763	N/A	N/A
Option	1 Mar 2022	Restricted Stock Units	2,763	N/A	N/A
Option	1 Feb 2022	Restricted Stock Units	3,125	N/A	N/A
Option	1 Feb 2022	Common Stock	6,770	N/A	N/A
Option	1 Feb 2022	Restricted Stock Units	3,645	N/A	N/A
Option	1 Oct 2021	Restricted Stock Units	4,375	N/A	N/A
Option	1 Oct 2021	Common Stock	4,375	N/A	N/A
Option	1 Sep 2021	Common Stock	2,762	N/A	N/A
Option	1 Sep 2021	Restricted Stock Units	2,762	N/A	N/A
Option	1 Aug 2021	Common Stock	6,770	N/A	N/A
Option	1 Aug 2021	Restricted Stock Units	6,770	N/A	N/A
Option	1 Apr 2021	Restricted Stock Units	4,375	N/A	N/A
Option	1 Apr 2021	Common Stock	4,375	N/A	N/A
Option	1 Feb 2021	Restricted Stock Units	6,770	N/A	N/A
Option	1 Feb 2021	Common Stock	6,770	N/A	N/A
Option	1 Oct 2020	Restricted Stock Units	4,375	N/A	N/A
Option	1 Oct 2020	Common Stock	4,375	N/A	N/A
Option	1 Aug 2020	Common Stock	6,770	N/A	N/A
Option	1 Aug 2020	Restricted Stock Units	6,770	N/A	N/A
Option	1 Aug 2020	Restricted Stock Units	6,770	N/A	N/A
Option	1 Apr 2020	Common Stock	4,375	N/A	N/A
Option	1 Apr 2020	Restricted Stock Units	4,375	N/A	N/A
Option	1 Feb 2020	Common Stock	3,125	$65.82	$205,687
Option	1 Feb 2020	Restricted Stock Units	3,125	$65.82	$205,687
Option	1 Oct 2019	Common Stock	4,375	N/A	N/A
Option	1 Oct 2019	Restricted Stock Units	4,375	N/A	N/A
Option	1 Aug 2019	Restricted Stock Units	3,125	N/A	N/A
Option	1 Aug 2019	Common Stock	3,125	N/A	N/A
Option	1 Apr 2019	Common Stock	8,750	N/A	N/A
Option	1 Apr 2019	Restricted Stock Units	8,750	N/A	N/A

Global Blood Therapeutics key executives

Global Blood Therapeutics, Inc. executives and other stock owners filed with the SEC:

Dr. Ted W. Love (66) Pres, Chief Executive Officer & Director
Mr. David L. Johnson (56) Chief Commercial Officer
Mr. Jeffrey S. Farrow (63) Chief Financial Officer & Principal Accounting Officer
Ms. Jung E. Choi (55) Chief Bus. & Strategy Officer
Ms. Patricia Borga Suvari (64) Chief Legal Officer & Sec.

David L. Johnson Net Worth